Synthetix Health secures $38M IPO-style Series D to commercialize synthetic medical data platform

Tech · 6 min read

Synthetix Health announced Synthetix Clinical Fabric, a platform that generates synthetic patient records, imaging priors, and longitudinal datasets for AI development and validation. The product includes statistical validation reports and differential-privacy options to meet regulatory scrutiny.

The company raised $38 million in a late-stage round led by HealthBridge Capital, positioning the raise as IPO-preparatory. Synthetix will use funds to scale generation capacity, build industry-specific templates, and expand partnerships with hospitals and EHR vendors.

Synthetix emphasizes that its products enable AI teams to train and test models without exposing PHI, and it provides auditing tools to demonstrate synthetic-to-real fidelity to regulators. Several medtech firms piloting the platform reported faster model iteration and smoother IRB discussions.